489 related articles for article (PubMed ID: 34016285)
1. Mucormycosis.
Steinbrink JM; Miceli MH
Infect Dis Clin North Am; 2021 Jun; 35(2):435-452. PubMed ID: 34016285
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary mucormycosis.
Hamilos G; Samonis G; Kontoyiannis DP
Semin Respir Crit Care Med; 2011 Dec; 32(6):693-702. PubMed ID: 22167397
[TBL] [Abstract][Full Text] [Related]
3. Breaking the Mold: A Review of Mucormycosis and Current Pharmacological Treatment Options.
Riley TT; Muzny CA; Swiatlo E; Legendre DP
Ann Pharmacother; 2016 Sep; 50(9):747-57. PubMed ID: 27307416
[TBL] [Abstract][Full Text] [Related]
4. Mucormycosis.
Reid G; Lynch JP; Fishbein MC; Clark NM
Semin Respir Crit Care Med; 2020 Feb; 41(1):99-114. PubMed ID: 32000287
[TBL] [Abstract][Full Text] [Related]
5. Novel perspectives on mucormycosis: pathophysiology, presentation, and management.
Spellberg B; Edwards J; Ibrahim A
Clin Microbiol Rev; 2005 Jul; 18(3):556-69. PubMed ID: 16020690
[TBL] [Abstract][Full Text] [Related]
6. An Unusual Case of Pulmonary Mucormycosis.
Thomas S; Pawar B; Fernandes D; Nayar S; George P; Cherian S
Transplant Proc; 2018 Dec; 50(10):3943-3945. PubMed ID: 30503525
[TBL] [Abstract][Full Text] [Related]
7. Mucormycosis: New Developments into a Persistently Devastating Infection.
Danion F; Aguilar C; Catherinot E; Alanio A; DeWolf S; Lortholary O; Lanternier F
Semin Respir Crit Care Med; 2015 Oct; 36(5):692-705. PubMed ID: 26398536
[TBL] [Abstract][Full Text] [Related]
8. Part 2: mucormycosis: focus on therapy.
Lynch JP; Zhanel GG
Expert Rev Anti Infect Ther; 2023; 21(7):737-748. PubMed ID: 37300820
[TBL] [Abstract][Full Text] [Related]
9. Mucormycosis: The hidden and forgotten disease.
Darwish RM; AlMasri M; Al-Masri MM
J Appl Microbiol; 2022 Jun; 132(6):4042-4057. PubMed ID: 35156271
[TBL] [Abstract][Full Text] [Related]
10. Our 2014 approach to mucormycosis.
Tacke D; Koehler P; Markiefka B; Cornely OA
Mycoses; 2014 Sep; 57(9):519-24. PubMed ID: 24829170
[TBL] [Abstract][Full Text] [Related]
11. A mucormycosis case in a cirrhotic patient successfully treated with posaconazole and review of published literature.
Lin SY; Lu PL; Tsai KB; Lin CY; Lin WR; Chen TC; Chang YT; Huang CH; Chen CY; Lai CC; Chen YH
Mycopathologia; 2012 Dec; 174(5-6):499-504. PubMed ID: 22744722
[TBL] [Abstract][Full Text] [Related]
12. Risk factors and outcomes of COVID associated mucormycosis in kidney transplant recipients.
Bansal SB; Rana A; Babras M; Yadav D; Jha P; Jain M; Sethi SK
Transpl Infect Dis; 2022 Apr; 24(2):e13777. PubMed ID: 34932870
[TBL] [Abstract][Full Text] [Related]
13. An extensive review on antifungal approaches in the treatment of mucormycosis.
Chaudhari HS; Palkar OS; Abha Mishra KM; Sethi KK
J Biochem Mol Toxicol; 2023 Sep; 37(9):e23417. PubMed ID: 37345721
[TBL] [Abstract][Full Text] [Related]
14. [Not Available].
Gholinejad Ghadi N; Seifi Z; Shokohi T; Aghili SR; Nikkhah M; Vahedi Larijani L; Ghasemi M; Haghani I
J Mycol Med; 2018 Jun; 28(2):399-402. PubMed ID: 29545122
[TBL] [Abstract][Full Text] [Related]
15. Mucormycosis in renal transplant recipients: review of 174 reported cases.
Song Y; Qiao J; Giovanni G; Liu G; Yang H; Wu J; Chen J
BMC Infect Dis; 2017 Apr; 17(1):283. PubMed ID: 28420334
[TBL] [Abstract][Full Text] [Related]
16. Bone and joint infections caused by mucormycetes: A challenging osteoarticular mycosis of the twenty-first century.
Taj-Aldeen SJ; Gamaletsou MN; Rammaert B; Sipsas NV; Zeller V; Roilides E; Kontoyiannis DP; Henry M; Petraitis V; Moriyama B; Denning DW; Lortholary O; Walsh TJ;
Med Mycol; 2017 Oct; 55(7):691-704. PubMed ID: 28053147
[TBL] [Abstract][Full Text] [Related]
17. Treatment of mucormycosis in transplant patients: role of surgery and of old and new antifungal agents.
Chitasombat MN; Kontoyiannis DP
Curr Opin Infect Dis; 2016 Aug; 29(4):340-5. PubMed ID: 27191199
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 Associated Rhino-Orbital-Cerebral Mucormycosis: Clinical Features, Antifungal Susceptibility, Management and Outcome in a Tertiary Hospital in Iran.
Abdorahimi M; Pakdel F; Salehi M; Alcazar-Fuoli L; Hashemi SJ; Daie Ghazvini R; Ahmadkhani F; Ahmadikia K; Abdollahi A; Debran JCS; Tabari A; Farrokh F; Mousavand A; Afarinesh Khaki P; Salami Khaneshan A; Ibrahim AS; Khodavaisy S
Mycopathologia; 2023 Oct; 188(5):783-792. PubMed ID: 37672164
[TBL] [Abstract][Full Text] [Related]
19. Clinical and microbiological features and outcomes of mucormycosis in critically ill patients.
Rothe K; Braitsch K; Okrojek R; Heim M; Rasch S; Verbeek M; Schmid RM; Busch DH; Lahmer T
Int J Infect Dis; 2021 Aug; 109():142-147. PubMed ID: 34229089
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous mucormycosis.
Skiada A; Petrikkos G
Skinmed; 2013; 11(3):155-9; quiz 159-60. PubMed ID: 23930354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
